Page last updated: 2024-10-25

cyclocreatine and Cell Transformation, Neoplastic

cyclocreatine has been researched along with Cell Transformation, Neoplastic in 2 studies

cyclocreatine: structure given in first source

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurmi, K1
Hitosugi, S1
Yu, J1
Boakye-Agyeman, F1
Wiese, EK1
Larson, TR1
Dai, Q1
Machida, YJ1
Lou, Z1
Wang, L1
Boughey, JC1
Kaufmann, SH1
Goetz, MP1
Karnitz, LM1
Hitosugi, T1
Lillie, JW1
O'Keefe, M1
Valinski, H1
Hamlin, HA1
Varban, ML1
Kaddurah-Daouk, R1

Other Studies

2 other studies available for cyclocreatine and Cell Transformation, Neoplastic

ArticleYear
Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.
    Cell metabolism, 2018, 12-04, Volume: 28, Issue:6

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Ce

2018
Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumors.
    Cancer research, 1993, Jul-01, Volume: 53, Issue:13

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Transformation, Neoplastic; Creatine

1993